Pain, Acute — Discomfort During Intravenous Cannulation in an Emergency Department: Impact of Communication
Citation(s)
Dutt-Gupta J, Bown T, Cyna AM Effect of communication on pain during intravenous cannulation: a randomized controlled trial. Br J Anaesth. 2007 Dec;99(6):871-5. Epub 2007 Oct 30.
Greville-Harris M, Dieppe P Bad is more powerful than good: the nocebo response in medical consultations. Am J Med. 2015 Feb;128(2):126-9. doi: 10.1016/j.amjmed.2014.08.031. Epub 2014 Sep 16. Review.
Nevin K Influence of sex on pain assessment and management. Ann Emerg Med. 1996 Apr;27(4):424-6. Review.
Pagé MG, Katz J, Stinson J, Isaac L, Martin-Pichora AL, Campbell F Validation of the numerical rating scale for pain intensity and unpleasantness in pediatric acute postoperative pain: sensitivity to change over time. J Pain. 2012 Apr;13(4):359-69. doi: 10.1016/j.jpain.2011.12.010. Epub 2012 Mar 15.
Singer AJ, Richman PB, Kowalska A, Thode HC Jr Comparison of patient and practitioner assessments of pain from commonly performed emergency department procedures. Ann Emerg Med. 1999 Jun;33(6):652-8.
Varelmann D, Pancaro C, Cappiello EC, Camann WR Nocebo-induced hyperalgesia during local anesthetic injection. Anesth Analg. 2010 Mar 1;110(3):868-70. doi: 10.1213/ANE.0b013e3181cc5727. Epub 2009 Dec 30.
Wells RE, Kaptchuk TJ To tell the truth, the whole truth, may do patients harm: the problem of the nocebo effect for informed consent. Am J Bioeth. 2012;12(3):22-9. doi: 10.1080/15265161.2011.652798.
Impact of Communication on Pain During Intravenous Cannulation in an Emergency Department: a Randomized Controlled Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
